Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial

Fig. 2

Comparison of the proportion of patients with sustained low disease activity (A) and remission (B) at baseline and weeks 8, 16, and 24. Bars indicate the percentage of patients, while data in the bars are the proportion of patients. The difference in proportion between the two arms and P-value of the logistic regression after adjusting for baseline Disease Activity Score-28 are shown above the bars. TAC, tacrolimus; TNFi, tumor necrosis factor inhibitor; MTX, methotrexate

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us